F.D.A. Faces Upset Over Denials of New Drugs

NYT Homepage

by Christina Jewett

March 5, 2026

Agency officials promise fast reviews of new treatments while vowing they will not be a “rubber stamp” for the industry. But patients with rare diseases view recent decisions as signs that the doors are closing on their options.

Verticals

newsgeneral

Originally published on NYT Homepage on 3/5/2026